Historic Opportunity to End Breast Cancer Launched Today

Pink Eraser Project Launch: Breast cancer survivors Kristen Dahlgren and Michele Young, with support from top doctors,

Accelerating Vaccine Development: The project aims to reduce the typical timeline for bringing breast cancer vaccines to market by 25 years 

Founders' Vision: Kristen Dahlgren and Michele Young stress the importance of focus, practical support, collaboration, and funding to leverage 

Harnessing Immune Systems: Young highlights the potential of existing vaccines in preventing breast cancer recurrence during early-stage trials

Memorial Sloan Kettering, Cleveland Clinic, and More: The Pink Eraser Project collaborates with renowned medical institutions like Memorial Sloan Kettering

Patient Success Stories: Jenni Davis, a triple negative breast cancer survivor, shares her positive experience with a vaccine from the Cleveland Clinic

Optimism from Researchers: Dr. Nora Disis of the University of Washington's Cancer Vaccine Institute underscores the progress in cancer vaccine research

Call for Coordinated Effort: Experts recommend a focused approach, involving vaccine and immunotherapy experts, pharmaceutical partners

You Should Know

Click on Below